DK136953B - Analogifremgangsmåde til fremstilling af pyrazol-4-eddikesyrederivater. - Google Patents

Analogifremgangsmåde til fremstilling af pyrazol-4-eddikesyrederivater.

Info

Publication number
DK136953B
DK136953B DK438174AA DK438174A DK136953B DK 136953 B DK136953 B DK 136953B DK 438174A A DK438174A A DK 438174AA DK 438174 A DK438174 A DK 438174A DK 136953 B DK136953 B DK 136953B
Authority
DK
Denmark
Prior art keywords
pyrazole
preparation
acetic acid
acid derivatives
analogous process
Prior art date
Application number
DK438174AA
Other languages
Danish (da)
English (en)
Other versions
DK438174A (xx
DK136953C (xx
Inventor
Georg Rainer
Richard Riedel
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of DK438174A publication Critical patent/DK438174A/da
Publication of DK136953B publication Critical patent/DK136953B/da
Application granted granted Critical
Publication of DK136953C publication Critical patent/DK136953C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • C07D231/22One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK438174AA 1973-08-16 1974-08-15 Analogifremgangsmåde til fremstilling af pyrazol-4-eddikesyrederivater. DK136953B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU68238A LU68238A1 (xx) 1973-08-16 1973-08-16

Publications (3)

Publication Number Publication Date
DK438174A DK438174A (xx) 1975-04-28
DK136953B true DK136953B (da) 1977-12-19
DK136953C DK136953C (xx) 1978-05-29

Family

ID=19727442

Family Applications (1)

Application Number Title Priority Date Filing Date
DK438174AA DK136953B (da) 1973-08-16 1974-08-15 Analogifremgangsmåde til fremstilling af pyrazol-4-eddikesyrederivater.

Country Status (18)

Country Link
JP (1) JPS5230515B2 (xx)
AT (1) AT339892B (xx)
BE (1) BE818912A (xx)
CA (1) CA1048499A (xx)
CH (1) CH601250A5 (xx)
DE (2) DE2462459C3 (xx)
DK (1) DK136953B (xx)
ES (1) ES429247A1 (xx)
FI (1) FI57584C (xx)
FR (1) FR2240732B1 (xx)
GB (1) GB1475806A (xx)
IE (1) IE39999B1 (xx)
LU (1) LU68238A1 (xx)
NL (1) NL169070C (xx)
NO (1) NO140733C (xx)
SE (1) SE409454B (xx)
YU (1) YU222474A (xx)
ZA (1) ZA745252B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5297383A (en) * 1976-02-13 1977-08-16 Ngk Spark Plug Co Ceramic honeycomb structures for exhaust gas purification
HUP0304101A3 (en) * 2003-12-22 2008-10-28 Sanofi Aventis Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates

Also Published As

Publication number Publication date
FI242274A (xx) 1975-02-17
DE2462459A1 (de) 1977-04-07
NL7410921A (nl) 1975-02-18
DE2462459B2 (de) 1979-02-08
FI57584C (fi) 1980-09-10
NL169070B (nl) 1982-01-04
SE7410419L (xx) 1975-02-17
GB1475806A (en) 1977-06-10
DE2438779B2 (de) 1979-01-25
ATA671174A (de) 1977-03-15
LU68238A1 (xx) 1975-05-21
IE39999B1 (en) 1979-02-14
DK438174A (xx) 1975-04-28
NO742941L (xx) 1975-03-17
SE409454B (sv) 1979-08-20
FR2240732B1 (xx) 1978-07-21
NO140733B (no) 1979-07-23
FI57584B (fi) 1980-05-30
NL169070C (nl) 1982-06-01
JPS5049278A (xx) 1975-05-01
DE2462459C3 (de) 1979-10-04
DK136953C (xx) 1978-05-29
ZA745252B (en) 1976-03-31
IE39999L (en) 1975-02-16
YU222474A (en) 1983-04-27
CA1048499A (en) 1979-02-13
DE2438779C3 (de) 1979-09-20
DE2438779A1 (de) 1975-02-27
FR2240732A1 (xx) 1975-03-14
BE818912A (fr) 1975-02-17
AT339892B (de) 1977-11-10
JPS5230515B2 (xx) 1977-08-09
ES429247A1 (es) 1976-08-16
NO140733C (no) 1979-10-31
CH601250A5 (xx) 1978-06-30

Similar Documents

Publication Publication Date Title
DK134345B (da) Analogifremgangsmåde til fremstilling af 4-hydroxymethyl-1-phthalazonderivater.
DK135376B (da) Fremgangsmåde til fremstilling af piperazinylquinazolin-forbindelser.
DK137277B (da) Analogifremgangsmåde til fremstilling af ferrocenforbindelser.
DK137835B (da) Analogifremgangsmåde til fremstilling af thienothiazinderivater.
DK140484B (da) Fremgangsmåde til fremstilling af zeaxanthin.
DK134031B (da) Fremgangsmåde til fremstilling af et endo-beta-glucanase-præparat.
DK138321B (da) Analogifremgangsmåde til fremstilling af 5-halogen-2,3-kresotinsyrederivater.
DK137679B (da) Analogifremgangsmåde til fremstilling af thienotriazoldiazepinderivater eller syreadditionssalte deraf.
DK137389B (da) Analogifremgangsmåde til fremstilling af 11beta-substituerede delta4-østrener.
DK134279B (da) Analogifremgangsmåde til fremstilling af cycloalkylphenoxycarboxylsyrederivater.
DK133977B (da) Fremgangsmåde til fremstilling af 2-chlor-5-sulfamoylbenzoesyrer.
DK134485B (da) Analogifremgangsmåde til fremstilling af thiocarbaminsyrederivater.
DK137577B (da) Fremgangsmåde til fremstilling af zeaxanthin.
DK139716B (da) Analogifremgangsmåde til fremstilling af 4-aminoamfetaminderivater.
DK133667B (da) Fremgangsmåde til fremstilling af 5-cyklohexyl-6-halogenindan-1-karboxylsyrederivater.
DK137043B (da) Analogifremgangsmåde til fremstilling af nitrocarbostyrilforbindelser.
DK140411B (da) Fremgangsmåde til fremstilling af deacetoxycephalosporin C.
DK135685B (da) Analogifremgangsmåde til fremstilling af morfolinderivater.
DK140431B (da) Analogifremgangsmåde til fremstilling af et N2-dansyl-L-arginin-derivat eller syreadditionssalte deraf.
DK135943B (da) Fremgangsmåde til fremstilling af propanolaminderivater.
DK134154B (da) Analogifremgangsmåde til fremstilling af 5-cyklohexyl-1-indankarboxylsyrederivater.
DK137182B (da) Analogifremgangsmåde til fremstilling af anthranilsyrederivater.
DK136619B (da) Fremgangsmåde til fremstilling af dihydrokanadensolid.
DK135120B (da) Analogifremgangsmåde til fremstilling af imidazolidinderivater.
DK138895B (da) Fremgangsmåde til fremstilling af 8-beta-(2'-pyrimidino-aminometyl)-ergolinderivater.